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ANNOUNCEMENTS
9–13 May, 2002
Seventh Eilat Conference on New Antiepileptic Drugs (Eilat VII)
Eilat, Israel (with a backup site in Italy)
The conference program is designed to provide critical reviews and updated information about new antiepileptic
drugs (AEDs) that are in different stages of development, as well as to present progress reports on recent findings
concerning marketed new antiepileptic drugs. In addition, sessions will be devoted to Advances in the Pathophys-
iology of Drug Resistance; New AEDs in Pediatric Epilepsy Syndromes; Modes of AED Action and Spectrum of
Adverse Effects; A Re-Appraisal of Comparative Responses to AEDs Combinations.
Language: English
Organizing Committee: Meir Bialer, Israel; Svein I. Johannessen, Norway; Harvey J. Kupferberg, USA;
Rene H. Levy, USA; Emilio Perucca, Italy; Torbjörn Tomson, Sweden
Secretariat: Target Tours Ltd, Eilat VII, PO Box 29041, Tel Aviv 61290, Israel.
Tel: +972 3 5175150; Fax: +972 3 5175155; E-mail: eilatvii@targetconf.com
Website: www.eilatvii.com
6–11 December, 2002
American Epilepsy Society – 56th Annual Meeting
Washington State Convention & Trade Center
Seattle, Washington – USA
For further information please contact:
Maria Rivera,
American Epilepsy Society
342 North Main Street
West Hartford, CT 06117-2507
USA
Tel: +1 (860) 586-7505
Fax: +1 (860) 586-7550
Email: info@aesnet.org
http://www.aesnet.org
13–14 December, 2002
The Mariani Foundation is organizing an international conference on Rasmussen’s
Syndrome bringing together major experts to further investigate mechanism,
management and long-term outcome
Milan, September 5th, 2002—The Pierfranco and Luisa Mariani Foundation for Paediatric Neurology is promoting
the second international symposium on Rasmussen’s syndrome—Mechanism, management and long-term out-
come, in cooperation with the Montreal Neurological Institute and Hospital and the National Neurologic Institute
“C. Besta” of Milan. The upcoming conference will take place on 13th and 14th December, 2002 in the truly appro-
priate setting of the Montreal Neurological Institute, where Theodore Rasmussen was active in his very productive
life, and where still today so much work is carried out on this rare and enigmatic disease.
“We can hope that delineation of the syndrome is the first step to understanding its cause and to devising specific
treatment and prevention. . . . . . ” With this sentence F. Andermann and T.B. Rasmussen concluded the book on
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Rasmussen’s Syndrome published in 1991. Ten years have passed and our scientific knowledge has been greatly
improved with new data and findings available.
It is now time to accept the challenge by Rasmussen and to reap the harvest of many scientists to outline the “Lights
and Shadows” of Rasmussen’s Encephalitis.
The meeting will develop over two days and the program of the conference will include:
• Clinical aspects and investigations: clinical updates, neurophysiology, imaging, neuropsychology
• Immunology of Rasmussen’s syndrome: diagnosis, experimental models, genetic components
• Immunological treatment of RE: diversified approaches, in children and adults
• Surgical treatment: techniques, timing and impact
• Perspectives of coordinated registers and multicenter study
INVITED PARTICIPANTS: E. Andermann (Montreal); F. Andermann (Montreal); J. Antel (Montreal); C. Antozzi
(Milan); G. Avanzini (Milan); A. Bar-Or (Montreal); G. Broggi (Milan); G. Capovilla (Mantova); B. Carson
(Baltimore); M. L. Chiapparini (Milan); H. Chugani (Detroit); D. Colman (Montreal); H. Cross (London); B. Dalla
Bernardina (Verona); O. Delalande (Paris); F. Dubeau (Montreal); O. Dulac (Paris); O. Eeg-Olofsson (Uppsala);
C. Bien (Bonn); W. Feindel (Montreal); J. Freeman (Baltimore); F. L. Fusco (Rome); G. Gobbi (Bologna); T. Granata
(Milan); A. Guekht (Moscow); I. Hart (Liverpool); Y. Hart (Oxford); M. Jones-Gotman (Montreal); M. Levite
(Rehovot); R. Mantegazza (Milan); J. McNamara (Durham); J.L. Montes (Montreal); H. Oguni (Tokyo); S. Baranzini
(San Francisco); A. Olivier (Montreal); C. Polkey (London); R. Riopelle (Montreal); Y. Robitaille (Montreal);
R. Spreafico (Milan); D. Tampieri (Montreal); L. Taylor (Montreal); J. Villemure (Lausanne); A. Vincent
(Oxford); E. Vining (Baltimore); H. Vinters (Los Angeles); E. Wyllie (Cleveland).
12–15 March, 2003
Sixth International Conference on Stroke and 3rd Conference of the Mediterranean Stroke Society
Venue: Monte Carlo, Monaco
Deadline for Receipt of Abstracts: November 1, 2002
For further information, please contact:
Stroke 6
Kenes International—Global Congress Organisers and Association Management Services P.O. Box 56, Ben Gurion
Airport 70100, Israel
Tel: +972 3 9727500
Fax: +972 3 9727555
E-mail: stroke6@kenes.com
